Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study

BACKGROUND: The effectiveness of messenger RNA coronavirus disease 2019 (COVID-19) vaccines in patients with atopic dermatitis (AD) is yet to be delineated. It remains largely unknown how AD-related immunosuppressive medications affect the development of vaccine-induced immunity. OBJECTIVE: We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kridin, Khalaf, Schonmann, Yochai, Onn, Erez, Bitan, Dana Tzur, Weinstein, Orly, Cohen, Arnon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924351/
https://www.ncbi.nlm.nih.gov/pubmed/35294720
http://dx.doi.org/10.1007/s40257-022-00672-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924351/
https://www.ncbi.nlm.nih.gov/pubmed/35294720
http://dx.doi.org/10.1007/s40257-022-00672-5

Ejemplares similares